Decoy-resistant IL-18 reshapes the tumor microenvironment and enhances rejection by anti-CTLA-4 in renal cell carcinoma.
Schoenfeld DA, Djureinovic D, Su DG, Zhang L, Lu BY, Kamga L, Mann JE, Huck JD, Hurwitz M, Braun DA, Jilaveanu L, Ring AM, Kluger HM.
Schoenfeld DA, et al. Among authors: kamga l.
JCI Insight. 2024 Nov 19:e184545. doi: 10.1172/jci.insight.184545. Online ahead of print.
JCI Insight. 2024.
PMID: 39561007
Free article.